Somewhere a founder is perfecting the drone that will win a shoot-off at Fort Benning and still lose the contract. That is not a knock on the airframe. It is the design of the program. The Pentagon’s Drone Dominance Program, nicknamed the Gauntlet, runs in phases, and the phase that matters most for any hardware founder is not the one where the prototype flies. It is the one where you have to prove you can build the thing at volume. The Phase II qualifier window is estimated for this month, and what it tests is the part most founders defer until it is too late.
The Gauntlet Separates the Demo From the Line
Phase I looked like a demo day with weapons. The military invited 25 vendors to compete, started evaluations at Fort Benning on February 18, and put roughly $150 million behind prototype deliveries over the months that followed. That is the part everyone photographs. Phase II is where the program shows its real intent. According to the program’s own structure, it opens with a production and delivery test to prove manufacturing readiness, then runs Gauntlet II to find the systems worth scaling, then ends with actual delivery orders going to the winners. Winners have to show they can produce capable, low-cost units with a secure supply chain at scale. The whole effort runs past a billion dollars across four phases, aimed at fielding hundreds of thousands of one-way attack drones by 2027. Read the sequence and the message is plain. The government is not buying the best drone. It is buying the best drone someone can actually build, again and again, on a line. Those are two different competitions, and plenty of companies that win the first one lose the second.
Why the Buyer Moved the Gate
The reason is stated openly in how the program is framed. The United States is behind China on manufacturing and fielding drones, not on designing clever ones. When the bottleneck is production, the buyer stops paying for the prototype and starts paying for the factory. This matches a signal I have watched the defense world send for a while now. The procurement language keeps pulling toward narrow, direct, producible systems and away from the general-purpose moonshot, because a narrow form factor is far easier to build, secure, and field than a do-everything platform. General-purpose is a fundraising story. Narrow and producible is a delivery story. A program organized as a manufacturing gauntlet is the buyer saying out loud which story it intends to fund. The founders who file manufacturing under “solve after the raise” are optimizing for the phase that no longer decides anything.
The Same Gate Shows Up in Every Regulated Market
None of this is a defense quirk. The buyer who gates on the production system, not the prototype, appears in every hard-tech market that matters. In MedTech, the FDA does not let you sell on a working bench unit either. Before a cleared device ships, you complete design transfer and validate the manufacturing process under 21 CFR 820, proving the line turns out the same device every time and not just the golden sample you demoed for the review team. A strategic acquirer runs the identical play in diligence. So does a serious first enterprise customer. The gates carry different names, but they ask one question: can you make this, repeatably, at the cost and volume your plan assumes? For a founder building drones, diagnostics, grid hardware, or surgical robots, the takeaway does not change. The prototype earns the meeting. The production system earns the order. If you are still raising on a hero demo and treating the factory as a line item for some later quarter, you are deferring the exact thing your buyer has decided to judge you on.
Dave’s take
I have watched more than one team celebrate a flawless demo and then learn the hard way that the demo and the product were two different machines. The Pentagon has now turned that lesson into a published phase, with money attached to clearing it. If your roadmap puts manufacturing readiness after the next milestone, you have the order backwards, because the milestone that counts is the one asking whether you can build it at all. Prove the line, not the prototype.
I’m here to help you scale.
Work With DavePrefer a smaller first step? Book a $500 one-hour consultation →
Dave Saunders is the founder of Base Reality Group and a Fractional CPO for hard-tech founders. He was a founder and operator at Galen Robotics, where the surgical-robotics platform earned FDA De Novo authorization in 2023, and he managed a 35-patent portfolio licensed from Johns Hopkins. He wrote Founders Who Finish and publishes The Build. More about Dave →